These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 23557078)

  • 1. Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study.
    Kahrilas PJ; Howden CW; Wernersson B; Denison H; Nuevo J; Gisbert JP
    Aliment Pharmacol Ther; 2013 May; 37(10):1005-10. PubMed ID: 23557078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of and impact of pantoprazole on nocturnal heartburn and associated sleep complaints in patients with erosive esophagitis.
    Kindt S; Imschoot J; Tack J
    Dis Esophagus; 2011 Nov; 24(8):531-7. PubMed ID: 21418126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and clinical implications of supraesophageal and dyspeptic symptoms in gastroesophageal reflux disease.
    Mearin F; Ponce J; Ponce M; Balboa A; Gónzalez MA; Zapardiel J
    Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):665-74. PubMed ID: 22330237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease.
    Kahrilas PJ; Jonsson A; Denison H; Wernersson B; Hughes N; Howden CW
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):612-9. PubMed ID: 22343515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.
    Johnson D; Crawley JA; Hwang C; Brown K
    Aliment Pharmacol Ther; 2010 Jul; 32(2):182-90. PubMed ID: 20456306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus.
    Eloubeidi MA; Provenzale D
    Am J Gastroenterol; 2000 Aug; 95(8):1881-7. PubMed ID: 10950030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD.
    Fass R; Johnson DA; Orr WC; Han C; Mody R; Stern KN; Pilmer BL; Perez MC
    Am J Gastroenterol; 2011 Mar; 106(3):421-31. PubMed ID: 21224838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of frequent nocturnal gastro-oesophageal reflux disease among employed adults: symptom severity, quality of life and work productivity.
    Dubois RW; Aguilar D; Fass R; Orr WC; Elfant AB; Dean BB; Harper AS; Yu HT; Melmed GY; Lynn R; Singh A; Tedeschi M
    Aliment Pharmacol Ther; 2007 Feb; 25(4):487-500. PubMed ID: 17270005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
    Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
    J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after short-term potent acid suppression therapy.
    Kahrilas PJ; Jonsson A; Denison H; Wernersson B; Hughes N; Howden CW
    Gut; 2014 May; 63(5):720-6. PubMed ID: 23831734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airway symptoms and sleeping difficulties in operated and non-operated patients with gastroesophageal reflux disease.
    Johannessen R; Petersen H; Olberg P; Johnsen G; Fjøsne U; Kleveland PM
    Scand J Gastroenterol; 2012 Jul; 47(7):762-9. PubMed ID: 22571295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study.
    Nocon M; Labenz J; Jaspersen D; Meyer-Sabellek W; Stolte M; Lind T; Malfertheiner P; Willich SN
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1728-31. PubMed ID: 17914941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD)--results from a cross-sectional study.
    Wahlqvist P; Carlsson J; Stålhammar NO; Wiklund I
    Value Health; 2002; 5(2):106-13. PubMed ID: 11918826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Night-time and daytime atypical manifestations of gastro-oesophageal reflux disease: frequency, severity and impact on health-related quality of life.
    Dean BB; Aguilar D; Johnson LF; McGuigan JE; Orr WC; Fass R; Yan N; Morgenstern D; Dubois RW
    Aliment Pharmacol Ther; 2008 Feb; 27(4):327-37. PubMed ID: 18005248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of reflux disease on general and disease-related quality of life - evidence from a recent comparative methodological study in Germany.
    Madisch A; Kulich KR; Malfertheiner P; Ziegler K; Bayerdörffer E; Miehlke S; Labenz J; Carlsson J; Wiklund IK
    Z Gastroenterol; 2003 Dec; 41(12):1137-43. PubMed ID: 14661122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.
    Johnson DA; Orr WC; Crawley JA; Traxler B; McCullough J; Brown KA; Roth T
    Am J Gastroenterol; 2005 Sep; 100(9):1914-22. PubMed ID: 16128933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Burden of illness in Polish patients with reflux disease].
    Reguła J; Kulich KR; Stasiewicz J; Jasiński B; Carlsson J; Wiklund I
    Przegl Epidemiol; 2005; 59(1):75-85. PubMed ID: 16013413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.
    Rush DR; Stelmach WJ; Young TL; Kirchdoerfer LJ; Scott-Lennox J; Holverson HE; Sabesin SM; Nicholas TA
    J Fam Pract; 1995 Aug; 41(2):126-36. PubMed ID: 7636452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep dysfunction in patients with gastro-oesophageal reflux disease: prevalence and response to GERD therapy, a pilot study.
    Chand N; Johnson DA; Tabangin M; Ware JC
    Aliment Pharmacol Ther; 2004 Nov; 20(9):969-74. PubMed ID: 15521844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease.
    Nojkov B; Rubenstein JH; Adlis SA; Shaw MJ; Saad R; Rai J; Weinman B; Chey WD
    Aliment Pharmacol Ther; 2008 Mar; 27(6):473-82. PubMed ID: 18194508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.